Joerg Benz
17Patents
3h-index
56Co-inventors
59Inventor score
Filing activity: Dec 22, 2008 → Sep 26, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11390610B2 | Piperazine derivatives as MAGL inhibitors | Chemistry; Metallurgy | 5 | Active |
| US11420961B2 | Heterocyclic compounds | Chemistry; Metallurgy | 5 | Active |
| US11608347B2 | Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10517945B2 | Covalently linked antigen-antibody conjugates | Chemistry; Metallurgy | 3 | Active |
| US9562091B2 | Humanized anti-Tau(pS422) antibodies and methods of use | Chemistry; Metallurgy | 3 | Active |
| US11814375B2 | Heterocyclic compounds | Chemistry; Metallurgy | 1 | Active |
| US10465000B2 | Humanized anti-Tau(pS422) antibodies and methods of use | Chemistry; Metallurgy | 1 | Active |
| US11981661B2 | Heterocyclic compounds | Chemistry; Metallurgy | 1 | Active |
| US11802133B2 | Heterocyclic compounds as monoacylglycerol lipase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11130804B2 | Antibody that binds to VEGF and IL-1beta and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12023378B2 | Covalently linked antigen-antibody conjugates | Chemistry; Metallurgy | 0 | Active |
| US10308710B2 | Humanized anti-Tau(pS422) antibodies and methods of use | General | 0 | Revoked |
| US8309340B2 | Insulin degrading enzyme crystals | Chemistry; Metallurgy | 0 | Active |
| US11866490B2 | Antibody that binds to VEGF and IL-1beta and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12281124B2 | Heterocyclic compounds as monoacylglycerol lipase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11192957B2 | Antibodies binding to HLA-A2/WT1 | Chemistry; Metallurgy | 0 | Active |
| US12098213B2 | Antibodies binding to HLA-A2/WT1 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.